title: Fas and Fas ligand interaction is necessary for human osteoblast apoptosis.
abstract: We investigated the cellular and humoral interactions between peripheral blood mononuclear cells (PBMCs) and human osteoblasts, leading to apoptosis of osteoblasts. Human osteoblastic cell line MG63 and human primary osteoblast-like cells obtained from biopsy specimens were used in this study. PBMCs were isolated from healthy donors and cultured with or without stimulation by recombinant interleukin-2 followed by 12-o-tetradecanoylphorbol 13-acetate with ionomycin. Fas was functionally expressed on MG63 and primary osteoblast-like cells. Activated PBMCs expressed Fas ligand (FasL) strongly on their surface and killed MG63 and primary osteoblast-like cells. Cultured supernatants of activated PBMCs also induced apoptotic cell death of MG63 and primary osteoblast-like cells. In contrast, both unstimulated PBMCs and cultured supernatants of unstimulated PBMCs did not induce apoptosis of these cells. Furthermore, the cytotoxic effect and induction of apoptosis against MG63 and primary osteoblast-like cells by activated PBMCs and cultured supernatants were inhibited significantly by human Fas chimeric protein. Our data showed that human osteoblasts expressed Fas fuctionally and both membrane-type and soluble form FasL from activated PBMCs induced apoptosis of these cells, providing the one possible mechanism of bone loss in inflammatory diseases such as rheumatoid arthritis.
authors.affiliation: The First Department of Internal Medicine, Nagasaki University School of Medicine, Japan.
authors.forename: A
authors.initials: A
authors.lastname: Kawakami
authors.forename: K
authors.initials: K
authors.lastname: Eguchi
authors.forename: N
authors.initials: N
authors.lastname: Matsuoka
authors.forename: M
authors.initials: M
authors.lastname: Tsuboi
authors.forename: T
authors.initials: T
authors.lastname: Koji
authors.forename: S
authors.initials: S
authors.lastname: Urayama
authors.forename: K
authors.initials: K
authors.lastname: Fujiyama
authors.forename: T
authors.initials: T
authors.lastname: Kiriyama
authors.forename: T
authors.initials: T
authors.lastname: Nakashima
authors.forename: P K
authors.initials: PK
authors.lastname: Nakane
authors.forename: S
authors.initials: S
authors.lastname: Nagataki
mesh_terms: D000954:Antigens, Surface / Q000096:biosynthesis; D017209:Apoptosis / Q000502:physiology*; D002460:Cell Line; D002478:Cells, Cultured; D053222:Fas Ligand Protein; D005786:Gene Expression Regulation / Q000187:drug effects / Q000235:genetics; D006801:Humans; D007075:Immunoglobulin M / Q000494:pharmacology; D015759:Ionomycin; D007476:Ionophores; D007963:Leukocytes, Mononuclear / Q000276:immunology / Q000502:physiology*; D008562:Membrane Glycoproteins / Q000096:biosynthesis; D010006:Osteoblasts / Q000276:immunology / Q000502:physiology*; D013755:Tetradecanoylphorbol Acetate; D019014:fas Receptor / Q000096:biosynthesis* / Q000276:immunology
chemical_list: D000954:Antigens, Surface; C505661:FASLG protein, human; D053222:Fas Ligand Protein; D007075:Immunoglobulin M; D007476:Ionophores; D008562:Membrane Glycoproteins; D019014:fas Receptor; D015759:Ionomycin; D013755:Tetradecanoylphorbol Acetate